Nimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model

This publication has 60 references indexed in Scilit:

• EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma
  BMC Cell Biology, 2013
• A view on EGFR-targeted therapies from the oncogene-addiction perspective
  Frontiers in Pharmacology, 2013
• Antiepidermal Growth Factor Receptor Therapy in Squamous Cell Carcinoma of the Head and Neck
  Journal of Oncology, 2012
• Biocompatibility, Biodistribution, and Drug‐Delivery Efficiency of Mesoporous Silica Nanoparticles for Cancer Therapy in Animals
  Small, 2010
• In Vitro Photodynamic Therapy with Chlorin e6 Leads to Apoptosis of Human Vascular Smooth Muscle Cells
  Archivum Immunologiae et Therapiae Experimentalis, 2010
• Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
  Cancer Research, 2009
• Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies
  British Journal of Cancer, 2009
• Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
  British Journal of Cancer, 2008
• Chlorin e6 – polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts
  BMC Pharmacology, 2007
• Antiproliferative, antiangiogenic and proapoptotic activity of h‐R3: A humanized anti‐EGFR antibody
  International Journal of Cancer, 2002